Trial Profile
An open-label pilot study of quetiapine addition to Oros methylphenidate in the treatment of ADHD [attention-deficit hyperactivity disorder] and high-aggression disruptive behavior disorders
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2015
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder; Behavioural disorders
- Focus Therapeutic Use
- 08 Apr 2009 Status changed from active, no longer recruiting to completed Last checked against ClinicalTrials.gov record.
- 08 Apr 2009 Status changed from active, no longer recruiting to completed Last checked against ClinicalTrials.gov record.
- 31 Dec 2005 New trial record.